Search clinical trials for: CP-526,555 (varenicline)

Total 1068 results

Olix Pharmaceuticals, Inc.
Trial Runners, LLC

Recruiting

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

United States
Prisma Health-Upstate
AstraZeneca; MedImmune LLC

Recruiting

Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors

Cancer | Rare Disease

United States
Pfizer

Completed

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

United States, Denmark, Slovakia, Canada, Australia, Argentina, Bulgaria, Netherlands, United Kingdom, Brazil, Finland, Greece
Pfizer

Completed

Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease

Hemodialysis | End-Stage Renal Disease

United States
Pfizer

Completed

A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Hepatic Insufficiency

United States
UConn Health
National Institute on Drug Abuse (NIDA)

Completed

Smoking Study With Behavioral Therapy for Hypertensive Patients (VANQUISH)

Hypertension | Cigarette Smoking

United States
Pfizer

Completed

Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking

Smoking Cessation

United States, Korea, Republic of, Brazil, Australia, Canada, United Kingdom, France, Czech Republic, Germany, Greece, Netherlands, Denmark, Taiwan, Argentina, Mexico
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Smoking | Schizophrenia | Craving

Canada
Pfizer

Completed

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of
University of Zagreb
Harvard Medical School (HMS and HSDM); University of Ljubljana School of Medicine... and other collaborators

Completed

Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting

Smoking Cessation

Croatia, Slovenia
Shaare Zedek Medical Center

Completed

Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?

Smoking Cessation

Israel
K.N. Roy Chengappa
National Institute of Mental Health (NIMH); Pfizer

Completed

Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder (BEST)

Smoking Cessation | Bipolar Disorder

United States
Institut fuer anwendungsorientierte Forschung und...
University Medical Center Goettingen

Completed

Sympathovagal Balance in Smoking Cessation

Smoking Cessation

Germany
Mayo Clinic

Completed

Lorcaserin for Preventing Weight Gain Among Smokers

Tobacco Use Disorder | Weight Gain

United States
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Plasticity in Schizophrenia (VAR-PAS)

Schizophrenia

Canada
Queen Mary University of London

Completed

Tailoring Varenicline to Individual Needs (TVIN Study) (TVIN)

Smoking Cessation | Tobacco Dependence

United Kingdom
Maastricht University Medical Center
Erasmus Medical Center; Jules Bordet Institute; Academisch Ziekenhuis Maastricht

Recruiting

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands, Belgium
National Cancer Institute (NCI)

Active, not recruiting

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Recurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7

United States
Virginia Commonwealth University

Recruiting

Decreasing Long-term Opioid Use in Cancer Survivors

Pain | Chronic Pain | Cancer Pain | Survivorship

United States
Pfizer

Completed

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Arthritis, Rheumatoid

United States, Czech Republic, Korea, Republic of, Mexico, Italy, India, Slovakia, Poland, Japan, Dominican Republic, Finland, Puerto Rico, Spain, Argentina, Bulgaria, Hungary, Brazil, Greece, Canada, Ukraine, Chile
Pfizer

Completed

Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers

Healthy

Singapore
Pfizer

Completed

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Obesity

United States
University of Michigan

Completed

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 (UdallP3)

Parkinson's Disease
University of Pennsylvania
Pfizer

Completed

Measuring Smoking Behaviors While Using Varenicline

Nicotine Dependence

United States
Mark Frye
Pfizer

Completed

Varenicline in Bipolar Depressed Patients (Varenicline)

Depression | Smoking | Bipolar Disorder

United States
Emory University
AstraZeneca

Completed

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Recurrent Small Cell Lung Carcinoma

United States
Pfizer

Terminated

A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects

Healthy Volunteers

United States
Riphah International University

Recruiting

Effects of Treadmill Training on Motor Function, Balance, and Spasticity Reduction in Children With Cerebral Palsy

Cerebral Palsy

Pakistan
University Hospital, Bordeaux
Ministry for Health and Solidarity, France

Completed

Total Disc Replacement Versus Anterior Cervical Decompression and Fusion (CERVIDISC)

Cervical Degenerative Disc Disease

France
VA Office of Research and Development

Completed

Brief Cognitive Behavioral Therapy for Chronic Pain

Musculoskeletal Pain | Chronic Pain

United States
Pfizer

Completed

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Crohn's Disease

Korea, Republic of, United States, Spain, Netherlands, Australia, Israel, Canada, Czechia, Japan, Germany, Hungary, Austria, Bulgaria, Greece, South Africa, Ukraine, France
Pfizer

Completed

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

Crohn's Disease

United States, Spain, Israel, Netherlands, Australia, Canada, Japan, Germany, Korea, Republic of, Hungary, Austria, Bulgaria, Czech Republic, Greece, South Africa, Ukraine, France
Pfizer

Completed

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis

United States, Canada
Pfizer

Completed

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis (OCTAVE)

Ulcerative Colitis

United States, Spain, Canada, Denmark, France, Australia, Belgium, Korea, Republic of, Hungary, Israel, Germany, Slovakia, Taiwan, Netherlands, Poland, New Zealand, United Kingdom, Japan, Austria, Estonia, Czechia, South Africa, Ukr... and more
Pfizer

Completed

A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease

Crohn's Disease

Netherlands, United States, Hungary, Belgium, Czech Republic, Italy, South Africa, Spain, United Kingdom, Slovakia, Poland, France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Pfizer

Terminated

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Lung Carcinoma

United States
University of Auckland, New Zealand

Terminated

Smoking Relapse Prevention Among COPD Ex-smokers (SPACE)

Smoking Cessation | Chronic Obstructive Pulmonary Disease

New Zealand
University of Pennsylvania
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Effects of Varenicline on Smoking Reminders (VSMK)

Nicotine Dependence

United States
National Cancer Institute (NCI)

Active, not recruiting

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Recurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7

United States
Mayo Clinic
Pfizer

Completed

Varenicline for Light Smokers (ChanLight)

Smoking

United States
National Cancer Institute (NCI)

Active, not recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Colorectal Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7

United States, Canada
Jonsson Comprehensive Cancer Center
AstraZeneca

Terminated

Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner

Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

Vaginal Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Advanced Cervical Adenocarcinoma | Human Papillomavirus-Related Cervical Squamous Cell Carcinoma | Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma | Stage III Cervical Cancer AJCC v8 | Stage IIIA... and other conditions

United States
University of Washington
National Cancer Institute (NCI); AstraZeneca

Terminated

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma

United States
VA Office of Research and Development

Recruiting

Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans (Vet Cat)

Tobacco Use Disorder | Cannabis Use Disorder

United States
Medical University of South Carolina

Completed

Varenicline for Adolescent Smoking Cessation

Nicotine Dependence

United States
Yuhan Corporation
Chonbuk National University Hospital

Completed

Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

Healthy Volunteer

Korea, Republic of
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Varenicline Treatment for Cannabis Use Disorder

Substance Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Varenicline on Cigarette Self Administration

Nicotine Dependence

United States
University of Minnesota
National Institute on Drug Abuse (NIDA); Pfizer

Completed

Human Laboratory Study Of Varenicline in Smokers

Nicotine Dependence

United States

Search clinical trials for: CP-526,555 (varenicline)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations